Oxygen Treatments Show Amazing Health Benefits!
Here’s What Researchers Have Said About EmergentO2™ Water Oxygenator (EWO*) Ingredients:

EWO stabilized oxygen is undoubtedly a new powerful tool in the modern world of medicine. The more we get to know about it, the more we can treat without side effects. EWO is a tool, a key to a noble dream for a better world, better life quality and life itself. EWO works as a strong antiseptic on the wound, killing anaerobic and fungal microorganisms. EWO increases the healing process. EWO was effective in dilutions and in the oral treatment of Stomatitis Aphthosa in the mouth and gums. EWO was effective as a topical treatment against Oral Cardidiasis and tongue’s fungal plaques. EWO was effective on degenerative lip dermatitis and Angulus Infectiosus in mouth angles. EWO was effective on eczematic areas as a moisturizing and skin repair agent.
Dr. Marios L. Christofinis, M.D., Ph.D.

I believe EWO, because of its inherent “energy factor” potential may just be the “Rosetta Stone” that unblocks the pathogenetic mechanisms of disease in general and provides the knowledge for proper disease prevention management. EWO Activated Oxygen is not simply an important nutrient supplement but a dynamic energy molecule. EWO has an extremely high ORP (Oxidation Reduction Potential) of 950 mV. That means EWO possesses energy that can be transferred to the surrounding environment, potentiating the bioenergetic processes and correcting or reversing underlying cellular dysfunctions. In other words, EWO works like a bright new cellular battery.
Menicos A. Spartalis, M.D., Vascular Surgeon

In the beginning I used EWO activated oxygen rather cautiously for cleaning the face for local uses thus assessing the action of this product as a bactericide. Later I started recommending it for the detoxification of the organism thus testing its activity for neutralizing free radicals. I gave it to my patients with tired and rather lifeless skin, with black circles under the eyes or individuals suffering from eczema and dermatitis. The results were fantastic and this made me bolder and able to recommend it to athletes, smokers, persons with feebleness, lack of energy, chronic bronchitis, asthma and to people with frequent viral infections due to a weakness in their immune system as well as to patients with bed-sores, etc. In all these cases the results have been excellent.
Dr. Margarita Chilindri, M.D., Pathology and Dermatology

From the results it is concluded that the ingestion of the activated oxygen solution of EWO considerably affects the tolerance levels of lactate acid in the blood and improves VO2max.
Nicos Yiannaki Pericleous, M.Sc., ACSM

The potential role of EWO stabilized liquid oxygen as an ergogenic aid in sports performance enhancement is still to be fully understood. Available scientific data and information on this subject presents a whole range of possibilities fur further studies. In this study it was established that there was not a far-reaching effect of EWO stabilized liquid oxygen on the same subjects in terms of performance enhancement during trial test sprints. However, a definite improvement was noticed in between the sprints of the trials with placebo and the controlled EWO stabilized liquid oxygen. This would indicate the fact that athletes who consumed EWO stabilized liquid oxygen were able to reproduce similar and sustained effort during both sprints as compared to those that consumed the placebo.
Dr. Hj Danish Zaheer Hj Zaheeruddin MD., PhD. And David Hennessy Bsc (Hons), Sports Medicine & Research Centre, Department of Youth & Sports, Brunei Darussalam

From my clinical experience this product can be used in all aspects of the oral medicine and surgery, for example
◊ As an irrigant for the cleaning and prophylaxis of the oral cavity
◊ For the treatment of periodontitis and gingivitis
◊ Post surgical procedures and post extracting treatment
◊ For biological treatment and elimination of amalgam filling and heavy metal drainage
◊ For therapy in a systemic disease, and many other applications
In conclusion, I would like to say that EWO because of its bio-friendly capabilities, it has the potential to be a powerful source for clinical or paramedical practice.
Dr. Stylianou Panayiotis, M.D.

This test represented a variety of individuals with varying physiological differences including age, sex, weight, medical health conditions, physical conditioning, etc. The test was conclusive on three major points:

1. Free oxygen (160) is present in EWO as it was absorbed into the blood stream both sublingually and/or internally after it was tagged with Protac C/Iodine26 in every administered case.
2. The combination of component ingredients in EWO has a positive affect, in varying degrees, on capillary dilation.
3. The combination of component ingredients in EWO has a significant affect on the reduction of systolic and diastolic blood pressure.

It is the researcher’s opinion that EWO results in greater metabolic efficiency which may correlate to significant energy reductions thus prolonging and enhancing the quality of an individual’s life. Further, EWO, used in conjunction with mineral supplements, may be an excellent therapeutic tool for treating physiological disorders including chronic fatigue syndrome, immune deficiency disorders and several chronic pain related disorders.
James D. Aker, Ph.D., M.S., P.A., P.P.A., President, Third State Analytical, Inc. Dr. Aker has a Ph.D. in Biochemistry, a Master’s Degree in Biochemistry (concentration: Organic Chemistry) and a Master’s Degree in Quantum Physics, Research. He is a Board Certified P.A. (Physician’s Assistant) and P.P.A. (Psychiatric Physician’s Assistant). For three years he served as a Nutritional Research Fellow with the World Health Organization (W.H.0.) in India (soil and nutritional analysis) and has spent the past 12 years as a biochemical, nutritional and medical research consultant specializing in nutritional product research, product development and product formulations.)

In short, in both measurable parameters and subjective observations, the test subjects in the group treated with the oxygen supplement EWO experienced the following to a greater degree than the control group: Greater stamina and endurance, Reduced muscle fatigue, More energy, Less “out of breath”, Greater feeling of strength, Felt that the product helped them perform better.
“Effect of stabilized oxygen consumed with water on blood and urine markers of oxidative stress and blood oxygen saturation during extended military mountaineering training at moderate altitude.” Eldon W. Askew, Ph.D. Department Chair, School of Nutrition, University of Utah, Donald E. Roberts, Ph.D., James E. Reading, M.A., Jeffrey M. Pfeiffer, M.S., Lt. Lance Orr, MC, USNR.

Blood gas analyses conducted on the participants’ arterial blood samples showed definite increases in arterial blood oxygen (PaO2), as well as elevated discharges of carbon dioxide waste matter. Older subjects appeared to respond better to the test product’s therapeutic actions, than was reported from younger recipients. The inclusion of an iron supplement with the test product indicates a helpful role in how the body utilizes “Vitamin O”. However, non-iron subjects also receiving test product posted higher-than-expected hemoglobin values, which suggests that the apparent blood-building action of “Vitamin O” can happen also without iron-dependency. A general stabilization of arterial blood oxygen levels following three months of steady supplementation with the test product became evident, but could change if daily intake were temporarily discontinued.
Dr. John Heinerman, Ph.D

* The term EWO has been used to replace the actual substance used for proprietary reasons.
Emergent Health Corp. All rights reserved.

This information is provided for reference purposes and is not intended to treat, cure, prevent or diagnose any disease or medical condition. None of the comments and/or findings quoted by researchers, labs or institutions mentioned above should be considered as an endorsement of EWO for any purpose whatsoever.

Footnotes:
1. Aker, James, Ph.D. "Capillary Microscope Oxygen Saturation Test", Orlando, FL.
Report #CM-AO2/310398 (unpublished), April 10, 1998.
2. Suntory International. "Testing to Assess the Effectiveness of Aquagen: Aquagen's
Effect On the Partial Pressure of Oxygen in Arterial Blood.". Tokyo, Japan (unpublished), May 2, 1996.
3. Guyton, Arthur C., M.D. & Hall, John E., Ph.D. Textbook of Medical Physiology. (Ninth Edition) W.B.
Saunders Company, Philadelphia: 1996, p. 45.
4. Ibid. pp. 44-45, 833, 837-44.
5. Ibid.
6. Ibid. p. 837.
7. Altman, Nathaniel. Oxygen Healing Therapies. Rochester, VT: Healing Arts Press, 1995.
8. "The Abyss Fluid Breathing," ScienceWeb, Starry Messenger Communications Feedback, 1996.
9. Detroit News. "People Are Talking -- Health: Oxygen-Rich Liquid Can Save Preemies."
Associated Press Release, September 12, 1996.

Note: in the mid 1990s, Alliance Pharmaceutical Corporation applied to the FDA for official approval to use its patented gas ventilation system (LiquiVent®) employing perflurochemical liquids which it calls "partial liquid ventilation". The approval is still pending.

Selected References:
1. Berkow, Robert, ed. 1999. The Merck Manual. 17th ed. Merck, Sharp & Dohme, Rahway, NJ.
2. Borror, Donald J. 1960. Dictionary of Root Words and Combining Forms. Mayfield Publ. Co.
3. Campbell, Neil A., Lawrence G. Mitchell, Jane B. Reece. 1999. Biology, 5th Ed. Benjamin/Cummings Publ. Co., Inc. Menlo Park, CA. (plus earlier editions)
4. Campbell, Neil A., Lawrence G. Mitchell, Jane B. Reece. 1999. Biology: Concepts and Connections, 3rd Ed. Benjamin/Cummings Publ. Co., Inc. Menlo Park, CA. (plus earlier editions)
5. Marchuk, William N. 1992. A Life Science Lexicon. Wm. C. Brown Publishers, Dubuque, IA.
6. Nunn JF. Oxygen: in applied respiratory physiology. 2nd Ed., Boston, Butterworths, 1977; Chap. 12, 375.
7. Hunt TK, Zederfeldt B, Goldstick TK. Oxygen and healing. Am Journ. Surg. 1969; 1(18):521-525.
8. Sheffield PJ. Tissue oxygen measurements. Davis JC (ed.), Problem Wounds, New York, Elsevier, 1988:17-53.
9. Prockop DJ, Kivirikko KI, Tuderman L. Biosynthesis of collagen and its disorders. N. Engl. Journ. Med. 1979; 301:13-21, 77-85.
10. Banda MI, Knighton DR, Hunt TK. Isolation of a non-mitogenic angiogenesis factor from wound fluid. Proc. Nat. Acad. Sci. USA. 1982; 79:7773.
11. Knighton DR, Hunt TK, Schevenstuhl H, et al. Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science. 1983; 221:1283-1285.
12. Babior BM. Oxygen dependent microbial killing by phagocytes. N. Engl. Journ. Med. 1974; 298:659-668, 721-726.
13. DeChatelet LR. Oxidative bactericidal mechanisms of polymorphonuclear leukocytes. Journ. Infect. Dis. 1975; 131:295-303.
14. Hohn DC. Oxygen and leukocyte microbial killing. Davis JC, Hunt TL (eds.), Hyperbaric Oxygen Therapy, Bethesda, Undersea Med. Soc. 1977:101-110.
15. Hohn DC. The effect of O2 tensions on the microbial function of leukocytes in wounds and in vitro. Surg. Forum. 1976; 27:18-20.
16. Mason PL, Heremans JF, Schonne E. Lactoferrin and iron binding protein in neutrophilic leukocytes. Journ. Exp. Med. 1969; 130:643-658.
17. Hunt TK, Knighton D, Goodson W. In Way L, Dunphy E (eds.), Current Surgical Diagnosis and Treatment. 7th Ed., Philadelphia, Lange Med. Pub., 1985; 99-128.
18. McCord JM. An enzyme-based theory of obligate anaerobiosis: the physiological function of superoxide dismutase. Proc. Nat. Acad. Sci. USA. 1971; 68:1024-1027.
19. Hill GB, Osterhour S. Experimental effects of hyperbaric oxygen on selected clostridial species. Journ. Infect. Dis. 1972; 125:17-25.
20. VanUnnik AJM. Inhibition of toxin production in Clostridium perfringens in vitro by hyperbaric oxygen. Antonie Leewenhoet Microbial. 1969; 31:181-186.
21. Hill GB. Hyperbaric oxygen exposure for intrahepatic abscesses produced in mice by nonspore forming anaerobic bacteria. Antimicrobial Agents Chemother. 1976; 9:312-317.
22. Schreiner A. Hyperbaric oxygen therapy in bacteroides infections. Acta. Chir. Scand. 1974; 140:73-76.
23. Watlyn RJ, et al. Treatment of anaerobic infection with hyperbaric oxygen. Surg. Clin. N. Amer. 1964; 44:107-112.
24. Brown GL. Effects of hyperbaric oxygen on S. aureus, P. aeruginosa, and C. albicans. Aviat. Space Environ. Med. 1979; 50:717-720.
25. Silver IA. The measurement of oxygen tension in healing tissue. In Herzog H (ed.), Progress in Respiration Research III, Basel; Skarger. 1969; 124-135.
26. Sheffield PJ. Tissue oxygen measurements with respect to soft tissue wound healing with normobaric and hyperbaric oxygen. Hyperbaric Oxygen Review. 1985; 6(1):18-46.
27. Knighton DR, Halliday B, Hunt TK. Oxygen as an antibiotic: a comparison of the effects of inspired oxygen concentration and antibiotic administration on in vivo bacterial clearance. Arch. Surg. 1986; 121:191-195.
28. Winter GD. Effects of hyperbaric oxygen treatment on epidermal regeneration. In W Iwa (ed.), Proceedings of the Fourth International Congress on Hyperbaric Medicine Behavior. Williams & Wilkins. 1970; 363-368.
29. Brosemer RW. The effect of oxygen tension on the growth and metabolism of a mammalian cell. Exp. Cell Res. 1961; 25:101-113.
30. Niinikoski J. Effect of oxygen supply on wound healing and formation of experimental granulation tissue. Acta. Physiol. Scand. 1969; 334:1-72.

Nothing in this article is to suggest medical advice or meant to diagnose, treat, prevent or cure any disease. The Food and Drug Administration has not approved any of these statements.  See your doctor if you have a medical condition.

This page was last modified: